Bolt Biotherapeutics
Earnings Surprise
Analysts estimated BOLT earnings of $-6.23 per share this quarter (Q4). BOLT's actual earnings were $-3.84 per share.
BOLT EPS surprise of 38.35%Analysts estimated BOLT earnings of $-5.90 per share this quarter (Q3). BOLT's actual earnings were $-3.72 per share.
BOLT EPS surprise of 36.99%Analysts estimated BOLT earnings of $-6.58 per share this quarter (Q2). BOLT's actual earnings were $-4.46 per share.
BOLT EPS surprise of 32.21%Analysts estimated BOLT earnings of $-7.39 per share this quarter (Q1). BOLT's actual earnings were $-5.80 per share.
BOLT EPS surprise of 21.57%Analysts estimated BOLT earnings of $-0.36 per share this quarter (Q3). BOLT's actual earnings were $-0.40 per share.
BOLT EPS surprise of -11.23%Analysts estimated BOLT earnings of $-0.49 per share this quarter (Q2). BOLT's actual earnings were $-0.46 per share.
BOLT EPS surprise of 6.05%Analysts estimated BOLT earnings of $-0.52 per share this quarter (Q1). BOLT's actual earnings were $-0.28 per share.
BOLT EPS surprise of 46.17%Analysts estimated BOLT earnings of $-0.49 per share this quarter (Q4). BOLT's actual earnings were $-0.47 per share.
BOLT EPS surprise of -4.34%Analysts estimated BOLT earnings of $-0.51 per share this quarter (Q3). BOLT's actual earnings were $-0.43 per share.
BOLT EPS surprise of -15.69%